Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,362 CHF | +1.11% | +3.51% | +25.20% |
04:11pm | Dsm-firmenich sees boost as weight-loss drugs spur healthier choices | RE |
07:14am | GIVAUDAN AG : Barclays Upgrades to Neutral | ZD |
Evolution of the average Target Price on Givaudan SA
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Givaudan SA
JPMORGAN | Celine Pannuti |
DEUTSCHE BANK RESEARCH | Virginie Boucher-Ferte |
UBS | |
JEFFERIES | Charlie Bentley |
BAADER BANK | Andreas von Arx |
BARCLAYS | Alex Sloane |
Stifel Nicolaus | |
GOLDMAN SACHS | Georgina Fraser |
Mirae Asset Group | |
Vista Partners | |
Berenberg Bank | |
BERENBERG | Samantha Darbyshire |
BERNSTEIN RESEARCH | Gunther Zechmann |
Gilford Securities | |
Bernstein | |
B. Riley | |
BNP Paribas | |
Societe Generale | |
Moors & Cabot | |
Morgan Stanley | |
CIBC World Markets | |
CREDIT SUISSE | Samuel Perry |
AlphaValue | |
DEUTSCHE BANK | Virginie Boucher-Ferte |
Euro Pacific Capital | |
KEPLER CHEUVREUX | Patrick Roquas |
Deutsche Bank Securities | |
Dawson James | |
Bryan, Garnier & Co. | |
Exane BNP | |
BANK OF AMERICA (BOFA) |
EPS Revisions
- Stock Market
- Equities
- GIVN Stock
- Consensus Givaudan SA